Drug Interactions and Hip Fracture Risk in Older Adults

NCT ID: NCT04731597

Last Updated: 2021-02-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

9721 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-08-16

Study Completion Date

2020-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Older people are in great risk of hip fracture for multiple reasons. Also they often are on medications for medical conditions. Hip fracture risk increases in relation to some medications. When older peoples take 2 or more medications they are in increase risk of hip fracture.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In this study the investigators describe medication intake profile and identify older people risk of hip fracture in relation to their medication when they are taken together.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hip Fractures

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cases with hip fracture

Patients afiliated to a HMO Plan de Salud Hospital Italiano who presented hip fracture between 2014 and 2019

drug interaction

Intervention Type DRUG

when two drugs are taken together

controls without hip fracture

Patients afiliated to a HMO Plan de Salud Hospital Italiano without hip fracture between 2014 and 2019

drug interaction

Intervention Type DRUG

when two drugs are taken together

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

drug interaction

when two drugs are taken together

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\* Affiliated patients to the HMO Plan de Salud Hospital Italiano at least 6 months affiliated.

older than 64 years old

\* affiliated between 01/07/2014 al 31/12/2019.

Exclusion Criteria

* Pathological Hip fracture
* bilateral elective hip replacement previous study period
Minimum Eligible Age

64 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospital Italiano de Buenos Aires

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

CRISTINA MARIA ELIZONDO

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital Italiano de Buenos Aires

CABA, Buenos Aires, Argentina

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Argentina

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

3804

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Polypharmacy Among Internal Medicine Patients
NCT05756400 ACTIVE_NOT_RECRUITING